AINewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Secures Rights to Proprietary Technology to Accelerate Development of AI-Enabled Application for Proposed Offering
Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, is announcing the acquisition of the rights to use certain AI-enabled technology from Ultiself, a top biohacking app. The acquisition aims to facilitate the development of the company’s tech for Gaxos Health. According to the announcement, the integration of Ultiself’s proprietary technology into Gaxos Health’s proposed product offering will enable improved customization and user experience. “By securing the rights to use this tech, we will be able to accelerate the development of our AI-enabled application for the Gaxos Health product offering,” said Vadim Mats, CEO of Gaxos.ai. “This…